Multiple Drug Adjuvant Chemotherapy for Patients with ER Negative Stage II Carcinoma of Breast

Enhancing nurse contributions to SWOG clinical trials

L Hansen;C Moinpour;R Ermete Seminars in Nursing Oncology 30(1):26-31;

PMid: PMID24559777 | PMC number: PMC3961058

Racial disparities in survival of patients with sex-specific cancers treated on Southwest Oncology Group clinical trials. PMC2724852; PMID: 19584328

KS Albain;JM Unger;JJ Crowley;CA Coltman;DL Hershman Journal of the National Cancer Institute 101(14):984-992

Minority report: how best to analyze clinical trial data to address disparities

D Hershman;J Unger Breast Cancer Research and Treatment 118:519-521

Outcome of African American women with breast cancer in cooperative group clinical trials

JM Unger;S Green;KS Albain Breast Cancer in Women of African Descent, Ch. 11, pp 267-295, C. Williams et al. (eds.), Springer, printed in Netherlands

Short-course FAC-M versus 1 year of CMFVP in node-positive, hormone receptor-negative breast cancer: An Intergroup study

GT Budd;S Green;RM O'Bryan;S Martino;MD Abeloff;JJ Rinehart;R Hahn;J Harris;D Tormey;J O'Sullivan;CK Osborne Journal of Clinical Oncology 13(4):831-839

Pitfalls in quality-of-life assessment: Lessons from a Southwest Oncology Group breast cancer clinical trial.

K Hayden;C Moinpour;B Metch;P Feigl;R O'Bryan;S Green;K Osborne Nurse Investigator 1(1):4

Pitfalls in quality-of-life assessment: Lessons from a Southwest Oncology Group breast cancer clinical trial.

KA Hayden;CM Moinpour;B Metch;P Feigl;RM O'Bryan;S Green;CK Osborne Oncology Nursing Forum 20(9):1415-1419

A comparison of CMFVP for one year to short term adriamycin based chemotherapy for patients with receptor-negative node positive operable breast cancer: An Intergroup study.

R O'Bryan;S Green;J O'Sullivan;D Tesh;W Knight;R McDivitt;W Jewell;M Abeloff;CK Osborne ASCO 11:61(#71)